• Philip W Moore, Robert B Palmer, and Joseph Ward Donovan.
• Department of Internal Medicine, PinnacleHealth Hospitalists, 111 S. Front St, Harrisburg, PA, 17101; Department of Internal Medicine, PinnacleHealth Toxicology Center, 111 S. Front St, Harrisburg, PA, 17101; Department of Emergency Medicine, Penn State University College of Medicine, 500 University Dr, Hershey, PA, 17033.
• J. Forensic Sci. 2015 Jan 1; 60 (1): 243-6.

AbstractOpioid-related mortality happens, even in healthcare settings. We describe serial postmortem fentanyl blood concentrations in a hospital inpatient who fatally abused transdermal fentanyl. This is a single-patient case report. A 42-year-old man with lymphoma was started on transdermal fentanyl therapy while hospitalized for chronic abdominal pain. The patient was last seen awake 1.3 h prior to being found apneic and cyanotic. During the resuscitation attempt, a small square-shaped film was removed from the patient's oropharynx. Femoral blood was collected 0.5 and 2 h postmortem, and the measured fentanyl concentration increased from 1.6 to 14 ng/mL. Study limitations include potential laboratory or collection errors and missing data. (i) Providers must be vigilant for signs of fentanyl patch abuse. (ii) Postmortem blood concentrations are not static postmortem, likely secondary to decreasing pH, increased aqueous solubility, and tissue redistribution, and are therefore unlikely to accurately represent antemortem blood concentrations.© 2014 American Academy of Forensic Sciences.

28 keywords...

hide…